Medicare Enrolled
Dr. Danny Nguyen, M.D.
Hematology & Oncology · Huntington Beach, CA
Practice pattern: Mixed Practice
— Diverse clinical practice across multiple procedure types
Mixed engagement
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Nguyen from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Nguyen?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Nguyen
Dr. Danny Nguyen is a hematology & oncology specialist in Huntington Beach, CA, with 15 years of NPI registration. Based on federal Medicare data, Dr. Nguyen performed 46,949 Medicare services across 1,120 unique beneficiaries.
Between the years covered by Open Payments, Dr. Nguyen received a total of $21,321 from 72 pharmaceutical and/or device companies across 513 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in hematology & oncology. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Nguyen is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 15 years in practice
▲ Top 16% volume in CA
$21,321 industry payments
Medicare Practice Summary
Medicare Utilization ↗46,949
Medicare services
Top 16% in CA for hematology & oncology
1,120
Unique beneficiaries
$12
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~3,130 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Iron infusion (Injectafer) An intravenous injection of ferric carboxymaltose, an iron replacement medication. |
25,500 | $1 | $4 |
| Pembrolizumab injection (Keytruda) | 7,400 | $43 | $194 |
| Denosumab injection (Prolia/Xgeva) | 5,880 | $19 | $83 |
| Anti-nausea injection (aprepitant) | 4,160 | $1 | $6 |
| Anti-nausea injection (ondansetron/Zofran) | 872 | $0 | $0 |
| Dexamethasone injection (steroid) An injection of dexamethasone sodium phosphate, a corticosteroid medication, administered in a dose of 1 milligram. |
612 | $0 | $0 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
466 | $69 | $321 |
| Intravenous injection of additional new drug or substance Administration of an additional new medication or substance directly into a vein. |
225 | $14 | $93 |
| Intravenous infusion, 1 hour or less Administration of medication or fluid directly into a vein for therapeutic, preventive, or diagnostic purposes. The procedure lasts one hour or less. |
210 | $58 | $269 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
183 | $105 | $445 |
| Intravenous chemotherapy infusion, 1 hour or less Administration of chemotherapy medication directly into a vein. The procedure takes one hour or less to complete. |
181 | $121 | $606 |
| Drug injection, under skin or into muscle A procedure involving the administration of a medication or substance via injection into the subcutaneous tissue or muscle. |
174 | $12 | $81 |
| Additional hour of intravenous infusion This code represents each additional hour of intravenous infusion beyond the initial hour for therapy, prevention, or diagnosis. |
170 | $18 | $88 |
| Hospital follow-up visit, low complexity Follow-up hospital visit for an established patient with straightforward or low-level medical decision making. The visit requires at least 25 minutes of time spent on the day of service. |
91 | $41 | $173 |
| Intravenous hydration infusion, 31-60 minutes Administration of fluids into a vein to maintain hydration. This procedure involves an infusion lasting between 31 and 60 minutes. |
89 | $29 | $220 |
| Additional hour of intravenous hydration This code represents each additional hour of intravenous fluid administration beyond the initial hour. It is used to bill for extended hydration therapy. |
83 | $11 | $69 |
| Normal saline infusion, 1000 cc Administration of 1000 cc of normal saline solution into a vein. This procedure involves the intravenous delivery of a sterile saltwater solution. |
71 | $2 | $9 |
| Diphenhydramine injection, up to 50 mg An injection of diphenhydramine hydrochloride, an antihistamine medication, administered in a dose of up to 50 milligrams. |
65 | $1 | $4 |
| Additional hour of intravenous chemotherapy This code represents the administration of chemotherapy medication into a vein for each additional hour beyond the initial period. |
59 | $25 | $134 |
| Telephone medical discussion, 5-10 minutes A phone conversation with a physician lasting between 5 and 10 minutes to discuss medical matters. |
56 | $30 | $209 |
| Additional sequential IV infusion, 1 hour or less This code represents an additional intravenous infusion administered sequentially to a primary infusion. It covers the administration time of one hour or less. |
45 | $26 | $147 |
| Intravenous infusion of new drug or substance, 1 hour or less This procedure involves administering a new medication or substance directly into a vein through an existing access site. The infusion is completed within one hour or less. |
44 | $59 | $295 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
43 | $117 | $555 |
| Unclassified drug A medication that does not fit into standard HCPCS or CPT classification categories. |
41 | $1 | $23 |
| Vitamin B-12 injection An injection of vitamin B-12 (cyanocobalamin) with a dose of up to 1000 mcg. |
40 | $1 | $5 |
| Blood sample collection from implanted device This procedure involves drawing a blood sample directly from a medical device that has been surgically placed in the body. |
39 | $25 | $109 |
| Office visit, established patient (10-19 min) An office visit for an existing patient lasting 10 to 19 minutes. The visit involves medical evaluation and management of the patient's condition. |
35 | $34 | $208 |
| New patient office visit (30-44 min) An initial office visit for a new patient lasting between 30 and 44 minutes. This code is used when the total time spent on the date of the encounter falls within this range. |
31 | $87 | $397 |
| Office visit, established patient, complex (40-54 min) An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter. |
28 | $139 | $641 |
| Telephone medical discussion, 11-20 minutes A phone conversation with a physician lasting between 11 and 20 minutes. |
25 | $55 | $327 |
| Advance care planning consultation, first 30 min A session focused on discussing and documenting future healthcare preferences and goals. This service covers the initial 30 minutes of the planning discussion. |
16 | $63 | $297 |
| Initial hospital admission, low complexity Initial hospital inpatient or observation care for a new patient involving straightforward or low-level medical decision making, with at least 40 minutes total time on the date of the encounter. |
15 | $65 | $301 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
56.0% high complexity
41.5% medium
2.5% routine
Industry Payment Transparency
Open Payments through 2024 ↗$21,321
Total received (2018-2024)
Avg $3,046/year across 7 years
Top 19% in CA for hematology & oncology
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
72
Companies
513
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$9,543 (44.8%)
Consulting
Expert advisory fees, typically reflecting recognized clinical expertise
$6,154 (28.9%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$5,624 (26.4%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$9,978
2023
$2,681
2022
$409
2021
$1,695
2020
$2,320
2019
$2,401
2018
$1,838
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
TAIHO ONCOLOGY, INC.
$5,418
Janssen Biotech, Inc.
$4,036
AIMMUNE THERAPEUTICS, INC.
$125
PFIZER INC.
$121
ADC Therapeutics America, Inc.
$114
Bayer Healthcare Pharmaceuticals Inc.
$109
Tempus AI, Inc
$29
Celgene Corporation
$25
Top 3 companies account for 96.0% of 2024 payments
All-time payments by company (2018-2024) ›
Janssen Biotech, Inc.
$6,903
TAIHO ONCOLOGY, INC.
$5,418
E.R. Squibb & Sons, L.L.C.
$833
Novartis Pharmaceuticals Corporation
$681
PFIZER INC.
$625
Merck Sharp & Dohme Corporation
$490
Pharmacyclics LLC, An AbbVie Company
$457
Amgen Inc.
$446
AstraZeneca Pharmaceuticals LP
$404
Bayer HealthCare Pharmaceuticals Inc.
$383
Genentech USA, Inc.
$274
Teleflex LLC
$214
Daiichi Sankyo Inc.
$210
Exelixis Inc.
$189
Celgene Corporation
$187
Incyte Corporation
$175
Medline Industries, Inc.
$157
AbbVie Inc.
$144
Takeda Pharmaceuticals U.S.A., Inc.
$138
Boehringer Ingelheim Pharmaceuticals, Inc.
$137
GENZYME CORPORATION
$126
AIMMUNE THERAPEUTICS, INC.
$125
Ipsen Biopharmaceuticals, Inc
$125
Janssen Scientific Affairs, LLC
$122
Regeneron Healthcare Solutions, Inc.
$116
Seagen Inc.
$115
ADC Therapeutics America, Inc.
$114
Astellas Pharma US Inc
$114
Bayer Healthcare Pharmaceuticals Inc.
$109
Gilead Sciences, Inc.
$108
EMD Serono, Inc.
$104
BeiGene USA, Inc.
$104
Puma Biotechnology, Inc.
$89
Foundation Medicine, Inc.
$82
AbbVie, Inc.
$81
TESARO, Inc.
$69
MEDIVATION FIELD SOLUTIONS LLC
$69
Eisai Inc.
$67
Integra LifeSciences Corporation
$67
Lilly USA, LLC
$61
Clovis Oncology, Inc.
$56
Seattle Genetics, Inc.
$55
Janssen Pharmaceuticals, Inc
$49
ABBVIE INC.
$46
CSL Behring
$46
Dendreon Pharmaceuticals LLC
$45
JAZZ PHARMACEUTICALS INC.
$42
AMAG Pharmaceuticals, Inc.
$38
Secura Bio, Inc.
$37
EUSA Pharma (US) LLC
$31
Myriad Genetic Laboratories, Inc.
$30
Tempus AI, Inc
$29
Epizyme, Inc.,
$29
GlaxoSmithKline, LLC.
$25
TerSera Therapeutics LLC
$25
Karyopharm Therapeutics Inc.
$24
Lexicon Pharmaceuticals, Inc.
$24
Kite Pharma, Inc.
$24
Myovant Sciences Inc.
$23
Servier Pharmaceuticals LLC
$21
Alexion Pharmaceuticals, Inc.
$20
Blueprint Medicines Corporation
$19
Teva Pharmaceuticals USA, Inc.
$18
Olympus America Inc.
$18
Janssen Research & Development, LLC
$16
Otsuka America Pharmaceutical, Inc.
$16
Sun Pharmaceutical Industries Inc.
$16
Mylan Institutional Inc.
$16
Coherus Biosciences Inc.
$16
Allergan Inc.
$15
Ferring Pharmaceuticals Inc.
$13
Fortovia Therapeutics, Inc.
$7
Top 3 companies account for 61.7% of all-time payments
Associated products mentioned in payments ›
ABECMA · ADCETRIS · Afstyla · Alecensa · Aliqopa · Avastin · BAVENCIO · BENDEKA · BOSULIF · BRAFTOVI · BRUKINSA · Bavencio · CALQUENCE · CAMZYOS · CHANTIX · CYRAMZA · Cabometyx · DARZALEX · DURYSTA · Dermatology and Wound Care · ELIQUIS · ELITEK · EMEND · EMPLICITI · ENHERTU · EVENITY · Enhertu · Erleada · FARYDAK · FASLODEX · FERAHEME · FIRMAGON · FOUNDATIONONE · Farydak · Fulphila · GAVRETO · GAZYVA · GILOTRIF · Hyalomatrix Wound Device · IBRANCE · IMBRUVICA · INJECTAFER · INLYTA · Imbruvica · JADENU · JAKAFI · JEVTANA · KANJINTI · KEYTRUDA · KISQALI · Kcentra · Kyprolis · LIBTAYO · LORBRENA · Lenvima · MEKINIST · MONJUVI · MVASI · MYLOTARG · NAMZARIC · NERLYNX · NUCALA · Nerlynx · Nexavar · Nplate · Nubeqa · OPDIVO · ORGOVYX · Olympus GI Accessories · PADCEV · PROMACTA · PROVENGE · Perjeta · QuikClot · REBLOZYL · RYBREVANT · RYDAPT · Reblozyl · Revlimid · Rubraca · SOMATULINE DEPOT · SPRYCEL · SURGIMEND · SUTENT · Soltamox · Stivarga · Sylvant · TAGRISSO · TASIGNA · TAZVERIK · TECENTRIQ · TIBSOVO · Udenyca · Ultomiris · VENCLEXTA · VERZENIO · VYXEOS · Vectibix · Venclexta · Vitrakvi · XALKORI · XARELTO · XGEVA · XOSPATA · XPOVIO · XTANDI · Xermelo · Xofigo · YONSA · ZEJULA · ZENPEP · ZOLADEX · myRisk
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Most payments (45%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.
Geographic Context
Hematology & oncology specialists within 10 mi
204
Per 100K population
6.4
County median income
$113,702
Nearest hospital
HUNTINGTON BEACH HOSPITAL
3.1 mi
3.1 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Nguyen is a mixed practice specialist, with above-average Medicare volume (top 16% in CA), with mixed engagement industry engagement in the top 19% of CA peers, with 15 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Nguyen experienced with iron infusion (injectafer)?
Based on Medicare claims data, Dr. Nguyen performed 25,500 iron infusion (injectafer) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Nguyen receive payments from pharmaceutical companies?
Yes. Dr. Nguyen received a total of $21,321 from 72 companies across 513 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Nguyen's costs compare to other hematology & oncology specialists in Huntington Beach?
Dr. Nguyen's average Medicare payment per service is $12. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Nguyen) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Same specialty & city
Hematology & Oncology Specialists in Huntington Beach
Browse hematology & oncology specialists in Huntington Beach ranked by procedure volume and transparency data.
Highest volume
Top Hematology & Oncology Specialists in CA
Hematology & oncology specialists ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Hematology & Oncology Specialists in CA
Which CA hematology & oncology specialists receive the most from drug and device companies.
By company
Janssen Biotech, Inc. Payments to Doctors
See all physicians who received payments from Janssen Biotech, Inc.
By company
TAIHO ONCOLOGY, INC. Payments to Doctors
See all physicians who received payments from TAIHO ONCOLOGY, INC.
By company
E.R. Squibb & Sons, L.L.C. Payments to Doctors
See all physicians who received payments from E.R. Squibb & Sons, L.L.C.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology